Company intelligence / Profile preview

Peptidus Biotech

Brasília, Distrito Federal, Brazilpeptidus.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Peptidus Biotech uses an AI-driven platform to discover and develop novel bioactive peptides for animal health therapies. The company leverages Brazil’s biodiversity to create next-generation peptide-based therapeutics targeting microbial diseases in veterinary medicine. Their approach emphasizes low toxicity, rapid absorption, and high specificity. Recent $17M seed funding will expand their technological pipeline and establish a synthetic expression system for scalable production. No clinical results reported yet; programs are at the preclinical R&D stage.

Therapeutic areas: Infectious Diseases
Modalities: Bioactive peptides
Industry: Veterinary

Drug pipeline

5 assets

MastPep

Pre-clinical

Indications: Bovine mastitis

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Peptidus Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidus Biotech.

Explore the full profile